|
| PF-06650833 Basic information |
Product Name: | PF-06650833 | Synonyms: | PF-06650833;1-(((2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide;6-Isoquinolinecarboxamide,1-(((2S,3S,4S)-3-ethyl-4-fluoro-5-oxo-2-pyrrolidinyl)methoxy)-7-methoxy-;PF06650833;PF 06650833;CS-2457;1-[[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxo-2-pyrrolidinyl]methoxy]-7-methoxy-6-isoquinolinecarboxamide;PF06650833 >=98% (HPLC);PF06650883 | CAS: | 1817626-54-2 | MF: | C18H20FN3O4 | MW: | 361.37 | EINECS: | | Product Categories: | API | Mol File: | 1817626-54-2.mol | |
| PF-06650833 Chemical Properties |
Boiling point | 621.0±55.0 °C(Predicted) | density | 1.34±0.1 g/cm3(Predicted) | storage temp. | room temp | solubility | DMSO : ≥ 33 mg/mL (91.32 mM) | pka | 13.44±0.70(Predicted) | form | powder | color | white to beige |
| PF-06650833 Usage And Synthesis |
Biochem/physiol Actions | PF06650833 has been studied for its use in the treatment of Waldenstrom macroglobulinemia, indicated by overproduction of IgM (immunoglobulin M)-producing lymphoplasmacytic cells. | storage | Store at -20°C |
| PF-06650833 Preparation Products And Raw materials |
|